KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
Swords, Ronan T., MD, PhD, FRCPI, FRCPath, Greenberg, Peter L., MD, Wei, Andrew H., MBBS, PhD, Durrant, Simon, MBBS, MRCS, LRCP, FRCP, FRCPath, Advani, Anjali S., MD, Hertzberg, Mark S., MBBS, PhD, FRACP, FRCPA, Lewis, Ian D., MBBS, PhD, Rivera, Gabriel, MD, Gratzinger, Dita, MD, PhD, Fan, Alice C., MD, Felsher, Dean W., MD, PhD, Cortes, Jorge E., MD, Watts, Justin M., MD, Yarranton, Geoff T., PhD, Walling, Jackie M., MB, ChB, PhD, Lancet, Jeffrey E., MD
Published in Leukemia research (01.11.2016)
Published in Leukemia research (01.11.2016)
Get full text
Journal Article
Corrigendum to “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study” [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729]
Swords, Ronan T., MD, PhD, Greenberg, Peter L., MD, Wei, Andrew H., MBBS, PhD, Durrant, Simon, MBBS, Advani, Anjali S., MD, Hertzberg, Mark S., MBBS, PhD, Lewis, Ian D., MBBS, PhD, Rivera, Gabriel, MD, Gratzinger, Dita, MD, PhD, Fan, Alice C., MD, Felsher, Dean W., MD, PhD, Cortes, Jorge E., MD, Watts, Justin M., MD, Yarranton, Geoff T., PhD, Walling, Jackie M., MB, ChB, PhD, Lancet, Jeffrey E., MD
Published in Leukemia research (01.08.2017)
Published in Leukemia research (01.08.2017)
Get full text
Journal Article
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy
Niyikiza, Clet, Baker, Sharyn D, Seitz, David E, Walling, Jackie M, Nelson, Katrina, Rusthoven, James J, Stabler, Sally P, Paoletti, Paolo, Calvert, A Hilary, Allen, Robert H
Published in Molecular cancer therapeutics (01.05.2002)
Get full text
Published in Molecular cancer therapeutics (01.05.2002)
Journal Article
Phase 1b Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Mims, Alice S., Solh, Melhem, Borate, Uma, Pemmaraju, Naveen, Borthakur, Gautam, Roboz, Gail J., Powell, Ben, Severson, Paul, Matusow, Bernice, Halladay, Jason, Hsu, Ching, Watkins, Paul, Zhang, Chao, Walling, Jackie M., Tsiatis, Athanasios C., DeZern, Amy E.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Final Results of a Phase 1b Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Mims, Alice S., Solh, Melhem, Saultz, Jennifer N., Borate, Uma, Pemmaraju, Naveen, Borthakur, Gautam, Roboz, Gail J., Powell, Ben, Matusow, Bernice, Halladay, Jason, Vali, Shireen, Hope, Chelsea L., Kundu, Madan G., Hsu, Ching, Watkins, Paul, Zhang, Chao, Walling, Jackie M., Tsiatis, Athanasios C., DeZern, Amy E.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Dose Escalation Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Pemmaraju, Naveen, Borate, Uma, Solh, Melhem, Borthakur, Gautam M., DeZern, Amy E., Zhang, Chao, Powell, Ben, Severson, Paul, Inokuchi, Kerry, Matusow, Bernice, Halladay, Jason, Hsu, Ching, Watkins, Paul, Walling, Jackie M., Tsiatis, Athanasios C., Mims, Alice S.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
An IHC Screen For EphA3 Positive FFPE Tumors
Locke, Darren, Bernstein, Steven, Lynch, Frank, Siami-Namini, Koushan, Walling, Jackie M., Yonker, Thomas, Yarranton, Geoffrey
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Analysis Of EphA3 Expression In Hematologic Malignancies By Quantitative PCR
Woronicz, John, Cortes, Jorge E., Jorgensen, Jeffrey L., Kantarjian, Hagop M, Ravandi, Farhad, Borthakur, Gautam, Challagundla, Pramoda, Matthews, Jairo, Ho, Jennifer, Walling, Jackie M., Yarranton, Geoffrey, Pemmaraju, Naveen
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
KB004, a Novel Non-Fucosylated Humaneered® Antibody, Targeting EphA3, Is Active and Well Tolerated in a Phase I/II Study of Advanced Hematologic Malignancies
Swords, Ronan T, Wei, Andrew H, Durrant, Simon, Advani, Anjali S., Hertzberg, Mark S, Lewis, Ian D, Greenberg, Peter L., Cortes, Jorge E., Yarranton, Geoff T, Walling, Jackie M., Lancet, Jeffrey E.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies
Lancet, Jeffrey E, Wei, Andrew H, Durrant, Simon TS, Hertzberg, Mark S., Swords, Ronan T., Lewis, Ian D, Jonas, Brian, Cortes, Jorge E., Yarranton, Geoffrey, Walling, Jackie M.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Homocysteine and Methylmalonic Acid: Markers to Predict and Avoid Toxicity from Pemetrexed Therapy 1 Supported by Eli Lilly and Company.1
Clet Niyikiza, Sharyn D. Baker, David E. Seitz, Jackie M. Walling, Katrina Nelson, James J. Rusthoven, Sally P. Stabler, Paolo Paoletti, A. Hilary Calvert, Robert H. Allen
Published in Molecular cancer therapeutics (01.05.2002)
Get full text
Published in Molecular cancer therapeutics (01.05.2002)
Journal Article